Literature DB >> 29665027

Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: Molecular analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP.

X Chen1, F Wang1, Y Zhang1, W Teng1, M Wang2, D Nie1, X Zhou3, D Wang3, H Zhao1, P Zhu2, H Liu1,4.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening hyperinflammatory disease. This study aimed to investigate the frequencies and distributions of inherited variants in PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP genes in Chinese patients with HLH. A total of 265 patients diagnosed with HLH from January, 2010 to December, 2016 were recruited and analyzed for the 6 genes. Genetic variants were observed in 87 (32.83%) patients. 36 (13.58%) exhibited variants in UNC13D, 18 (6.79%) exhibited PRF1 variants, 10 (3.77%) had variants in XIAP, 9 (3.40%) exhibited variants in STXBP2, 6 (2.26%) carried variants in SH2D1A, 1 (0.38%) had STX11 variant, and 7 (2.64%) exhibited digenic variants. Monoallelic variants were the most common, which accounted for 49.43% of all cases with variants. All variants were confirmed to be germline-derived. The present study describes a distinct variant spectrum in Chinese patients with HLH, whereby UNC13D is the most frequently mutated gene with missense variants that are the most common molecular defects. The variant profile of Chinese HLH patients is quite different from that of Western cohorts but similar to that of Korean patients, yet showing its own uniqueness. This racial difference shows the role of genetic background in the occurrence of HLH.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  gene variants; hemophagocytic lymphohistiocytosis; racial differences; variant spectrum

Mesh:

Substances:

Year:  2018        PMID: 29665027     DOI: 10.1111/cge.13363

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

Review 1.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

2.  Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders.

Authors:  Vanessa Gadoury-Levesque; Lei Dong; Rui Su; Jianjun Chen; Kejian Zhang; Kimberly A Risma; Rebecca A Marsh; Miao Sun
Journal:  Blood Adv       Date:  2020-06-23

3.  Pathogenic Gene Mutations or Variants Identified by Targeted Gene Sequencing in Adults With Hemophagocytic Lymphohistiocytosis.

Authors:  Yi Miao; Hua-Yuan Zhu; Chun Qiao; Yi Xia; Yiling Kong; Yi-Xin Zou; Yu-Qing Miao; Xiao Chen; Lei Cao; Wei Wu; Jin-Hua Liang; Jia-Zhu Wu; Li Wang; Lei Fan; Wei Xu; Jian-Yong Li
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

Review 4.  Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies.

Authors:  Halil Yildiz; Sarah Bailly; Eric Van Den Neste; Jean Cyr Yombi
Journal:  Ther Clin Risk Manag       Date:  2021-04-14       Impact factor: 2.423

5.  Adult onset type 2 familial hemophagocytic lymphohistiocytosis with PRF1 c.65delC/c.163C>T compound heterozygous mutations: A case report.

Authors:  Xin-Yi Liu; Yan-Bo Nie; Xue-Jing Chen; Xiao-Hui Gao; Li-Jia Zhai; Feng-Ling Min
Journal:  World J Clin Cases       Date:  2021-04-06       Impact factor: 1.337

Review 6.  Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.

Authors:  Camille Keenan; Kim E Nichols; Sabrin Albeituni
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

7.  A Case of Recurrent Pregnancy-Induced Adult Onset Familial Hemophagocytic Lymphohistiocytosis.

Authors:  Lan Y Wang; John Hu; Giridharan Ramsingh; Bassam Theodory; Bassam Yaghmour; Maria Vergara-Lluri; George Yaghmour
Journal:  World J Oncol       Date:  2018-09-06

8.  X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.

Authors:  Tao Xu; Qin Zhao; Wenyan Li; Xuemei Chen; Xiuhong Xue; Zhi Chen; Xiao Du; Xiaoming Bai; Qian Zhao; Lina Zhou; Xuemei Tang; Xi Yang; Hirokazu Kanegane; Xiaodong Zhao
Journal:  Eur J Pediatr       Date:  2019-11-21       Impact factor: 3.183

9.  Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.

Authors:  Ru-Yue Chen; Xiao-Zhong Li; Qiang Lin; Yun Zhu; Yun-Yan Shen; Qin-Ying Xu; Xue-Ming Zhu; Zhen-Jiang Bai; Ying Li
Journal:  BMC Pediatr       Date:  2020-10-02       Impact factor: 2.125

10.  A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults.

Authors:  Abraham Kwak; Nani Jung; Ye Jee Shim; Heung Sik Kim; Hyun Ji Lim; Jae Min Lee; Mi Hwa Heo; Young Rok Do
Journal:  Yeungnam Univ J Med       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.